AVR 1.01% $19.95 anteris technologies ltd

Anteris technologies yesterday announced that the first 5...

  1. 18,442 Posts.
    lightbulb Created with Sketch. 405
    Anteris technologies yesterday announced that the first 5 patients have successfully been implanted with Anteris’s DurAVR Valve.


    An additional 5 patients are planned for treatment in the first quarter of 2022 to conclude the study.


    This is a massive step towards FDA approval as AVR’s technology shows:

    1. Avoids the need for open heart surgery
    2. AVR’s heart valve have shown no calcification over 10 years – therefore avoids repeat surgery, and allows younger patients to be treated
    3. Early signs from first 5 patients have shown DurAVR providing superior haemodynamics
    4. Commissural alignment, flow characteristics and haemodynamics were proven to be clinically significant
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$19.95
Change
0.200(1.01%)
Mkt cap ! $383.4M
Open High Low Value Volume
$19.95 $20.00 $19.83 $183.2K 9.187K

Buyers (Bids)

No. Vol. Price($)
1 25 $19.75
 

Sellers (Offers)

Price($) Vol. No.
$19.95 472 1
View Market Depth
Last trade - 16.10pm 14/06/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.